Family Medicine · Tallahassee, FL
NPI
1053384164
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1720 S Gadsden St
Tallahassee, FL, 32301
Phone (850) 576-4073
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,298
220 services
Medicare patients, 2024
83
Average age 65
Drug cost, 2024
$2.5M
6,390 prescriptions
Company payments, 2025
$545
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Damon C McMillan was code 82962 (clinical chemistry), 93 times for 59 patients. In total Damon C McMillan billed 220 services in 20 codes, and Medicare paid $1,298.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-10-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 82962 Clinical Chemistry | Office | 93 | 59 | $3.21 | $299 |
| 83036 Blood Count | Office | 77 | 55 | $9.52 | $733 |
| 82947 Clinical Chemistry | Office | 17 | 13 | $3.85 | $65.45 |
By year: 2022 $353 for 45 services; 2023 $460 for 68 services; 2024 $1,298 for 220 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 93 | 59 | $3.21 | $299 |
| 83036 Blood Count | 77 | 55 | $9.52 | $733 |
| 82947 Clinical Chemistry | 17 | 13 | $3.85 | $65.45 |
Medicare prescription drug claims, 2024
In 2024, the drug Damon C McMillan prescribed most often to Medicare patients was Amlodipine Besylate, with 318 prescriptions and refills. In total Damon C McMillan wrote 6,390 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 318 | 699 | 73 | $2,083 |
| Atorvastatin Calcium Generic | 280 | 558 | 71 | $1,884 |
| Gabapentin Generic | 204 | 282 | 36 | $3,144 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 198 | 202 | 41 | $6,960 |
| Tivicay Dolutegravir Sodium | 170 | 170 | 15 | $362K |
| Metformin Hcl Generic | 159 | 284 | 32 | $870 |
| Tamsulosin Hcl Generic | 145 | 284 | 33 | $1,463 |
| Pravastatin Sodium Generic | 143 | 228 | 23 | $1,127 |
| Omeprazole Generic | 133 | 239 | 28 | $1,715 |
| Lisinopril Generic | 119 | 268 | 34 | $903 |
| Metoprolol Succinate Generic | 115 | 201 | 25 | $1,375 |
| Famotidine Generic | 113 | 180 | 24 | $1,330 |
| Furosemide Generic | 100 | 140 | 16 | $317 |
| Potassium Chloride Generic | 99 | 146 | 13 | $839 |
| Prezcobix Darunavir/Cobicistat | 93 | 93 | Under 11 | $213K |
Brand drugs: 1,528 claims; generic drugs: 4,830 claims; opioid claims: 68.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Damon C McMillan $545 ($545 in general payments such as food, travel and fees) from 10 companies. The largest payer was Gilead Sciences, Inc. with $124.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 5 | $124 |
| ViiV Healthcare Company GSK | 4 | $97.18 |
| Merck Sharp & Dohme LLC MRK | 3 | $88.33 |
| Dexcom, Inc. DXCM | 2 | $73.13 |
| GlaxoSmithKline, LLC. GSK | 1 | $54.19 |
| Novo Nordisk Inc NVO | 1 | $31.12 |
| Pfizer Inc. PFE | 1 | $23.61 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $20.39 |
| Seqirus USA Inc CSL.AX | 1 | $17.38 |
| Xeris Pharmaceuticals, Inc. | 1 | $16.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.